Zachariah Holmes

ID: 1b83cf18-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Celltrion Adalimumab Biosimilar Granted Interchangeability Designation

Big Molecule Watch · April 18, 2025

EU Biosimilar Regulatory and Launch Updates

Big Molecule Watch · February 7, 2025

Amgen Files BPCIA Complaint Against Accord Biopharma Regarding Denosumab Biosimilar

Big Molecule Watch · November 18, 2024

FDA Approves Ustekinumab, Aflibercept, and Filgrastim Biosimilars

Big Molecule Watch · July 9, 2024

Amgen Files BPCIA Complaint Against Celltrion Regarding Denosumab

Big Molecule Watch · June 5, 2024